The New York Mets are facing a significant challenge as right-hander Frankie Montas has been sidelined due to a high-grade lat strain. Montas, who signed a two-year, $34 million contract with the Mets this offseason, received a platelet-rich plasma (PRP) injection and is expected to be out for 6-8 weeks. This timeline suggests he may not return to the rotation until mid-May. Despite this setback, Montas remains optimistic about his recovery and future contributions to the team.
In response to Montas’s injury, Mets manager Carlos Mendoza has expressed confidence in the team’s existing pitching depth. Internal options such as Tylor Megill and Paul Blackburn are being considered to fill the vacancy in the rotation. Blackburn, in particular, is making a comeback after undergoing surgery in October to repair a cerebrospinal fluid leak and is currently competing for a spot in the rotation. Mendoza has indicated that the team plans to maintain a six-man rotation, relying on these internal candidates to step up during Montas’s absence.
While the Mets have been linked to external options, including free agent Jose Quintana and potential trade targets like Dylan Cease, there is no indication that the team is actively pursuing additional starting pitching at this time. The front office appears to be prioritizing internal solutions to address the current gap in the rotation. This approach suggests a level of confidence in the organization’s pitching depth and a desire to avoid parting with top prospects or making significant financial commitments in response to Montas’s injur
y.
Leave a Reply